Dolutegravir (GSK1349572) - CAS 1051375-16-6
Catalog number:
B0084-438457
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C20H19F2N3O5
Molecular Weight:
419.38
COA:
Inquire
Targets:
HIV
Description:
Dolutegravir (GSK1349572) is a two-metal-binding HIV integrase inhibitor with IC50 of 2.7 nM, modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-438457 25 mg $298 In stock
Bulk Inquiry
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
S/GSK1349572
MSDS:
Inquire
1.Dolutegravir: an exciting new kid on the block.
Blanco Arévalo JL1, Whitlock GG. Expert Opin Pharmacother. 2014 Mar;15(4):573-82. doi: 10.1517/14656566.2014.868883. Epub 2014 Jan 22.
INTRODUCTION: Dolutegravir is the first second-generation integrase inhibitor approved for the treatment of naïve as well as experienced HIV-infected individuals.
2.Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection.
Rathbun RC1, Lockhart SM, Miller MM, Liedtke MD. Ann Pharmacother. 2014 Mar;48(3):395-403. doi: 10.1177/1060028013513558. Epub 2013 Nov 19.
OBJECTIVE: To review the pharmacology, safety, and efficacy of dolutegravir, an integrase strand-transfer inhibitor (INSTI), and to discuss its role in the treatment of HIV-1-infected patients.
3.Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.
Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutiérrez F, Hocqueloux L, Maggiolo F, Sandkovsky U, Granier C, Pappa K, Wynne B, Min S, Nichols G; SINGLE Investigators. N Engl J Med. 2013 Nov 7;369(19):1807-18. doi: 10.1056/NEJMoa1215541.
BACKGROUND: Dolutegravir (S/GSK1349572), a once-daily, unboosted integrase inhibitor, was recently approved in the United States for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in combination with other antiretroviral agents. Dolutegravir, in combination with abacavir-lamivudine, may provide a simplified regimen.
4.Dolutegravir: a new integrase strand transfer inhibitor for the treatment of HIV.
Shah BM1, Schafer JJ, Desimone JA Jr. Pharmacotherapy. 2014 May;34(5):506-20. doi: 10.1002/phar.1386. Epub 2013 Dec 18.
The first two integrase strand transfer inhibitors (INSTIs) approved for treatment of patients infected with human immunodeficiency virus (HIV) were raltegravir and elvitegravir. Both raltegravir and elvitegravir are now guideline-preferred agents as part of an antiretroviral regimen for treatment-naive patients. However, raltegravir is dosed twice/day. Elvitegravir is available in a single-tablet regimen and dosed once/day because it is administered with the pharmacokinetic booster cobicistat, a potent CYP3A4 inhibitor that can lead to clinically significant drug-drug interactions. In addition, raltegravir and elvitegravir have a low genetic barrier to resistance and are associated with cross-resistance. Dolutegravir is a new-generation INSTI administered once/day without a pharmacokinetic booster and can be coformulated in a single-tablet regimen. Phase III studies have demonstrated the efficacy and safety of dolutegravir for treatment-naive and treatment-experienced patients.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HIV Products


CAS 147127-20-6 Tenofovir

Tenofovir
(CAS: 147127-20-6)

Tenofovir blocks reverse transcriptase and hepatitis B virus infections.

CAS 174484-41-4 Tipranavir

Tipranavir
(CAS: 174484-41-4)

Tipranavir, a nonpeptidic HIV protease inhibitor (NPPI), inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against mult...

CAS 157810-81-6 Indinavir sulfate

Indinavir sulfate
(CAS: 157810-81-6)

Indinavir is a protease inhibitor used as a component of highly active antiretroviral therapy to treat HIV infection and AIDS. It inhibits the HIV-1 protease wi...

CAS 333353-44-9 NBD-556

NBD-556
(CAS: 333353-44-9)

NBD-556 is small molecule mimetic of CD4. NBD-556 recognizes the HIV-1 envelope protein gp120 and induces restructuring of gp120 analogous to CD4 binding. The C...

CAS 30516-87-1 Zidovudine

Zidovudine
(CAS: 30516-87-1)

Zidovudine is a nucleoside reverse transcriptase inhibitor that, following triphosphorylation by thymidine kinase, potently blocks replication of HIV (EC50 = 3 ...

CAS 20633-67-4 Calycosin-7-O-beta-D-glucoside

Calycosin-7-O-beta-D-glucoside
(CAS: 20633-67-4)

Calycosin-7-O-β-D-glucoside, a melanin biosynthesis inhibitor, is isolated from the methanol extract of astragalus. It showed scavenging activity to DPPH radica...

CAS 150378-17-9 Indinavir

Indinavir
(CAS: 150378-17-9)

Indinavir is a member of the novel hydroxyaminopentane amide class of HIV-1 protease inhibitors. Indinavir is used as an antiviral.

CAS 129618-40-2 Nevirapine

Nevirapine
(CAS: 129618-40-2)

Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS.

CAS 729607-74-3 BMS-707035

BMS-707035
(CAS: 729607-74-3)

BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 of 15 nM.

D77
(CAS: 497836-10-9)

D77 is anti-HIV-1 inhibitor, which inhibits HIV-1(IIIB) replication (EC50=23.8 μM)

CAS 155213-67-5 Ritonavir

Ritonavir
(CAS: 155213-67-5)

Ritonavir is a very potent inhibitor of CYP3A4 mediated testosterone 6β-hydroxylation with mean Ki of 19 nM and also inhibits tolbutamide hydroxylation with IC5...

CAS 229975-97-7 Atazanavir Sulfate

Atazanavir Sulfate
(CAS: 229975-97-7)

Atazanavir is a HIV protease inhibitor with Ki of 2.66 nM. It is an antiretroviral drug of the protease inhibitor (PI) class. Like other antiretrovirals, it is ...

CAS 244767-67-7 Dapivirine

Dapivirine
(CAS: 244767-67-7)

CAS 864953-39-9 BMS-663068 Tris

BMS-663068 Tris
(CAS: 864953-39-9)

BMS-663068 tris is an HIV-1 attachment inhibitor in development for the treatment of HIV-1 infection.

CAS 149845-06-7 Saquinavir Mesylate

Saquinavir Mesylate
(CAS: 149845-06-7)

Saquinavir is an HIV Protease Inhibitor used in antiretroviral therapy. It inhibits both HIV-1 and HIV-2 proteases. Studies have also looked at saquinavir as a ...

CAS 143491-57-0 Emtricitabine

Emtricitabine
(CAS: 143491-57-0)

Emtricitabine moderately reduces hepatocyte proliferation independent of effects on mtDNA in HepG2 human hepatoma cells.

CAS 202138-50-9 Tenofovir Disoproxil Fumarate

Tenofovir Disoproxil Fumarate
(CAS: 202138-50-9)

Tenofovir Disoproxil Fumarate belongs to a class of antiretroviral drugs, it inhibits the activity of HIV reverse transcriptase by competing with the natural su...

CAS 379270-37-8 GS-7340

GS-7340
(CAS: 379270-37-8)

Tenofovir Alafenamide is a prodrug of Tenofovir, which is a reverse transcriptase inhibitor used to treat HIV and Hepatitis B. Antiviral.

CAS 544467-07-4 HIV-1 integrase inhibitor

HIV-1 integrase inhibitor
(CAS: 544467-07-4)

HIV-1 integrase inhibitor is uesful for anti-HIV, which can target HIV-1 integrase and depress the activity in the treatment of HIV infection, AIDS, and other s...

PD 135390
(CAS: 150351-31-8)

PD 135390 has been found to be a HIV-1 protease inhibitor that could probably be effective against HIV infections.

Chemical Structure

CAS 1051375-16-6 Dolutegravir (GSK1349572)

Quick Inquiry

Verification code

Featured Items